T48.0X3
Poisoning by oxytocic drugs, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by oxytocic drugs, coded as T48.0X3 in the ICD-10 classification, refers to an adverse or harmful reaction resulting from the ingestion, exposure, or administration of medications that are intended to induce uterine contractions. These drugs, while vital in obstetric care, can pose dangers if misused, overused, or administered maliciously. This particular code specifically addresses poisoning cases resulting from assault, highlighting situations where these medications are used intentionally to cause harm. Understanding this condition is important for healthcare professionals, forensic investigators, and patients to recognize the risks associated with oxytocic drugs in contexts of abuse or violence.
Causes & Symptoms
Clinical Causes: Intentional administration of oxytocic drugs during assault or abuse situations Misuse or overdosage of oxytocic medications Incorrect administration by healthcare providers leading to accidental poisoning Illicit procurement and use of these drugs for malicious intent Surreptitious use of oxytocic drugs outside medical supervision
Key Symptoms: Severe abdominal pain or cramping Nausea and vomiting Rapid or abnormal uterine contractions Uterine rupture or damage Heavy bleeding or hemorrhage Signs of hypersensitivity such as rash or swelling Dizziness or lightheadedness Potential fetal distress in pregnant women
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, patient history, and laboratory testing. Healthcare providers may consider:
Treatment Protocols: Treatment strategies depend on the severity and context of poisoning. They typically involve:
Clinical Advice & FAQs
Billing Guidance
Is T48.0X3 a billable ICD-10 code?
Yes, T48.0X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T48.0X3?
Clinical documentation must specify the nature of Poisoning by oxytocic drugs, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference